This multi-center clinical trial is designed to assess the association of diabetes in a cornea donor with transplant success and loss of endothelial cells 5 years following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes in a masked fashion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
570
Replacement of the recipient corneal endothelial and Descemet membrane with healthy tissue from a donor cornea.
Georgia Eye Partners
Atlanta, Georgia, United States
NOT_YET_RECRUITINGPrice Vision Group
Indianapolis, Indiana, United States
RECRUITINGUniversity of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
NOT_YET_RECRUITINGKansas City Eye Clinic
Overland Park, Kansas, United States
NOT_YET_RECRUITINGHuffman and Huffman, PSC
Lexington, Kentucky, United States
NOT_YET_RECRUITINGMid-Atlantic Cornea Consultants
Baltimore, Maryland, United States
NOT_YET_RECRUITINGThe Wilmer Eye Institute/Johns Hopkins
Baltimore, Maryland, United States
NOT_YET_RECRUITINGUniversity of Michigan/Kellogg Eye Center
Ann Arbor, Michigan, United States
NOT_YET_RECRUITINGVerdier Eye Center
Grand Rapids, Michigan, United States
RECRUITINGMinnesota Eye Consultants
Bloomington, Minnesota, United States
NOT_YET_RECRUITING...and 4 more locations
Change in central corneal endothelial cell density 5 years after Descemet membrane endothelial keratoplasty.
Central corneal endothelial cell density will be assessed by specular microscopy at 3 and 5 years after Descemet membrane endothelial keratoplasty and the results will be compared with the baseline donor endothelial cell density assessed at the eye bank that provided the donor tissue.
Time frame: Subjects are followed for 5 years after corneal transplantation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.